- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Health
Daily Deal Round Up: July 14, 2021
Electric aircraft developer Heart Aerospace raised $35m from investors including Mesa Air and United, while several corporates are set to exit remote access software developer Openpath.
Jul 14, 2021Prime Medicine presents $315m in funding
GV has contributed to two rounds for the gene-editing technology developer, which publicly launched yesterday with $315m of funding.
Jul 14, 2021Nimbus Therapeutics nabs $105m in funding
Access Biotechnology helped the small molecule drug developer increase its total funding to over $300m in a round led by BVF Partners.
Jul 14, 2021Adlai Nortye adds $100m in series D round
Tigermed and WuXi Biologics took part in the biopharmaceutical company's series D round, which will accelerate the development of its immuno-oncology drug candidates.
Jul 14, 2021Mobilion makes a mark with $60m
Existing investor Agilent helped the biomedical analysis technology developer close a series C round that pushed its overall funding past $110m.
Jul 14, 2021ProfoundBio procures over $55m
Lilly Asia Ventures co-led a series A round for ProfoundBio that will help it develop its novel technology and targeted cancer therapeutics.
Jul 14, 2021Mobilion makes a mark with $60m
IP Group has returned for a series C round for the PNNL spinout, having already backed the series A and B rounds.
Jul 14, 2021Tenaya Therapeutics tenses for IPO
Th heart disease treatment developer has secured $248m in funding since being formed to exploit UT Southwestern and Gladstone Institute research.
Jul 13, 2021Rani Therapeutics runs toward public markets
Alphabet, GeneScience, AstraZeneca, Shire, Novartis, Ping An, KPC and Stevanato are in line for exits after the drug delivery technology developer filed to go public.
Jul 13, 2021Nalu Medical signals public listing
The Boston Scientific-backed medical device maker has filed to raise up to $100m in an offering on the Nasdaq Global Market.
Jul 13, 2021Tenaya Therapeutics tenses for IPO
The GV-backed heart disease treatment developer intends to go public this year having secured $248m in venture funding.
Jul 13, 2021Synyi AI accumulates series E funding
The Tencent, China Electronics Corporation, Sinopharm and Sunshine Insurance-backed healthcare efficiency software provider raised $77.2m in the round.
Jul 12, 2021Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
